PAFSC 2nd Committee Endorses Approval of AZ’s Vandetanib

August 5, 2015
The Pharmaceutical Affairs and Food Sanitation Council’s (PAFSC) Second Committee on Drugs, an advisory organ to the health minister, recommended on August 3 approval of AstraZeneca K.K.’s (AZ) anticancer drug vandetanib for unresectable medullary thyroid cancer. The drug has already...read more